文献速递泌尿系结石

铥光纤激光与钬钇铝石榴石激光碎石术的比较:系统综述与荟萃分析

Thulium Fiber Laser Versus Holmium:Yttrium Aluminum Garnet for Lithotripsy: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur Urol · 2024-01-29

该系统综述与荟萃分析纳入11项研究,比较铥光纤激光(TFL)与钬钇铝石榴石(Ho:YAG)激光碎石疗效,TFL组880例、Ho:YAG组1286例。在无残留碎片标准下TFL无结石率更高(OR 1.84,95%CI 1.06-3.20;p=0.031),肾结石更高(OR 3.14,95%CI 1.69-5.86;p<0.001),输尿管结石无差异;TFL术中并发症更低(OR 0.34,95%CI 0.19-0.63;p<0.001)。

要点

  • 无残留碎片标准下TFL无结石率高于Ho:YAG(OR 1.84,95%CI 1.06-3.20;p=0.031)。
  • 肾结石TFL无结石率更高(OR 3.14,95%CI 1.69-5.86;p<0.001),输尿管结石无差异。
  • TFL术中并发症低于Ho:YAG(OR 0.34,95%CI 0.19-0.63;p<0.001)。

核心结论

  • TFL是治疗泌尿系结石有前景的激光,相较Ho:YAG具有一定优势。
  • 需进一步高质量研究证实这些发现并优化手术设置。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed/Medline、Embase和Web of Science数据库至2023年5月,遵循PRISMA指南。
  • 纳入11项研究,Ho:YAG组1286例、TFL组880例接受激光碎石的患者。
  • 多数研究纳入输尿管镜(URS)和逆行肾内手术,两项纳入经皮肾镜取石术,一项仅纳入URS;仅两项研究报告儿科患者结果。

主要发现

  • 无残留碎片标准下TFL无结石率高于Ho:YAG(OR 1.84,95%CI 1.06-3.20;p=0.031)。
  • 无结石率定义为存在<3 mm碎片时,TFL与Ho:YAG无显著差异(OR 2.48,95%CI 0.98-6.29;p=0.055)。
  • 仅考虑采用MOSES技术的Ho:YAG时,无结石率无显著差异(p=0.068)。
  • 肾结石TFL无结石率高于Ho:YAG(OR 3.14,95%CI 1.69-5.86;p<0.001),输尿管结石无差异(p=0.8)。
  • TFL术中并发症率低于Ho:YAG(OR 0.34,95%CI 0.19-0.63;p<0.001);主要并发症(p=0.4)、总体并发症(p=0.4)、手术时间(p=0.051)和激光时间(p=0.9)无差异。

临床怎么用

  • 作者认为TFL是治疗泌尿系结石有前景的激光,相较Ho:YAG具有一定优势。
  • 作者指出需进一步高质量研究证实这些发现并优化手术设置。

局限性

  • 需进一步高质量研究证实这些发现并优化手术设置。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Thulium fiber laser (TFL) emerged as a competitor of holmium:yttrium aluminum garnet (Ho:YAG) laser for the treatment of urinary stones. OBJECTIVE: To compare the efficacy between Ho:YAG and TFL for laser lithotripsy of renal and ureteral stones. EVIDENCE ACQUISITION: A literature search was conducted using PubMed/Medline, Embase, and Web of Science databases to identify reports published until May 2023. The Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were followed to identify eligible studies. The primary outcome was to compare the stone-free rate (SFR) between Ho:YAG and TFL for laser lithotripsy. EVIDENCE SYNTHESIS: Eleven studies met our inclusion criteria, and data from 1286 and 880 patients who underwent, respectively, Ho:YAG and TFL laser lithotripsy were reviewed. Most studies included ureteroscopy (URS) and retrograde intrarenal surgeries as procedures, two included percutaneous nephrolithotomy, and one included URS exclusively. Only two studies reported results in pediatric patients. TFL was associated with a higher SFR (odds ratio [OR] 1.84, 95% confidence interval [CI]: 1.06-3.20; p = 0.031) when no residual fragment is considered, but not when SFR refers to the presence of fragments <3 mm (OR 2.48, 95% CI: 0.98-6.29; p = 0.055) or when only Ho:YAG with MOSES is considered (p = 0.068). According to the stones' location, TFL was associated with higher SFRs than Ho:YAG for renal (OR 3.14, 95% CI: 1.69-5.86; p < 0.001) but not for ureteral (p = 0.8) stones. TFL was associated with a lower intraoperative complication rate (OR 0.34, 95% CI: 0.19-0.63; p < 0.001). No difference was found in major (p = 0.4) or overall (p = 0.4) complication rate, operative time (p = 0.051), and laser time (p = 0.9). CONCLUSIONS: TFL is a promising laser for the treatment of urinary stones with some advantages over Ho:YAG. Further high-quality studies are needed to confirm these findings and optimize the surgical settings. PATIENT SUMMARY: The use of thulium fiber laser rather than holmium:yttrium aluminum garnet permits to reach a higher stone-free rate in stones located in the kidney rather than in the ureter.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Uleri A, Farré A, Izquierdo P, et al. Thulium Fiber Laser Versus Holmium:Yttrium Aluminum Garnet for Lithotripsy: A Systematic Review and Meta-analysis. Eur Urol. 2024. PMID: 38290963. doi:10.1016/j.eururo.2024.01.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。